Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.33.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-76.17
EARNINGS PER SHARE (EPS) AVG 3Y
-936.34
EARNINGS PER SHARE (EPS) AVG 5Y
-837.30
EARNINGS PER SHARE (EPS) AVG 10Y
-457.37
EARNINGS PER SHARE (EPS) AVG 15Y
-163.03
EARNINGS PER SHARE (EPS) AVG 20Y
-487.25
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
IM Cannabis Corp.
Market Cap
$1.16M
Earnings Per Share (EPS)
N/A
TTM Avg
-76.17
3Y Avg
-936.34
5Y Avg
-837.30
Market Cap
$1.18M
Earnings Per Share (EPS)
-19.33
TTM Avg
-12.55
3Y Avg
-11.71
5Y Avg
-15.69
Market Cap
$1.10M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.03
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$1.31M
Earnings Per Share (EPS)
-158.78
TTM Avg
-3127.89
3Y Avg
-13218.44
5Y Avg
-15729.46
Market Cap
$1.06M
Earnings Per Share (EPS)
-89.20
TTM Avg
-39.24
3Y Avg
-1704.73
5Y Avg
-1696.36
Market Cap
$1.39M
Earnings Per Share (EPS)
N/A
TTM Avg
-14.23
3Y Avg
-10.02
5Y Avg
-9.01
Market Cap
$1.40M
Earnings Per Share (EPS)
-74.28
TTM Avg
-29.19
3Y Avg
-19.57
5Y Avg
-19.24
Market Cap
$1.02M
Earnings Per Share (EPS)
-8.02
TTM Avg
-25.27
3Y Avg
-9.38
5Y Avg
-7.51
Market Cap
$1.45M
Earnings Per Share (EPS)
-30.76
TTM Avg
-1622.27
3Y Avg
-9301.43
5Y Avg
-16503.78
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IM Cannabis Corp. (IMCC) | $1.16M | N/A | -76.17 | -936.34 | -837.30 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | -19.33 | -12.55 | -11.71 | -15.69 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | -0.03 | 0.05 | 0.05 |
| Genprex, Inc. (GNPX)vs › | $1.31M | -158.78 | -3127.89 | -13218.44 | -15729.46 |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | -89.20 | -39.24 | -1704.73 | -1696.36 |
| NewcelX Ltd. (NCEL)vs › | $1.39M | N/A | -14.23 | -10.02 | -9.01 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.40M | -74.28 | -29.19 | -19.57 | -19.24 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -8.02 | -25.27 | -9.38 | -7.51 |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | -30.76 | -1622.27 | -9301.43 | -16503.78 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | -10.02 | -4.85 | -7.18 | -7.18 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -58.33 |
| 2024-12-31 | -94.02 |
| 2023-12-31 | -100.73 |
| 2022-12-31 | -3492.27 |
| 2021-12-31 | -441.15 |
| 2019-12-31 | -318.53 |
| 2018-12-31 | 13.19 |
| 2018-04-30 | -54.20 |
| 2017-04-30 | -6.60 |
| 2016-04-30 | -21.04 |
| 2015-04-30 | -18.14 |
| 2014-04-30 | -128.04 |
| 2013-04-30 | -3699.25 |
| 2012-04-30 | -372.43 |
| 2011-04-30 | -519.39 |
| 2010-04-30 | -1145.93 |
| 2009-04-30 | -1268.51 |
| 2008-04-30 | -1153.83 |
| 2007-04-30 | -1128.17 |
| 2006-04-30 | -1954.68 |
| 2005-04-30 | -12.63 |
| 2004-04-30 | -1668.21 |
| 2003-04-30 | -2971.14 |
| 2002-04-30 | -20667.96 |
| 2001-04-30 | -19347.91 |
| 2000-04-30 | -29250.72 |
| 1999-04-30 | -86499.00 |
| 1998-04-30 | -55352.88 |
| 1997-04-30 | -46357.92 |
